| Historic (1865-12-01 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
mice
|
4568 |
17905.3 |
  |
| 2 |
mouse
|
1219 |
5147.9 |
  |
| 3 |
BALB/c
|
652 |
4482.7 |
  |
| 4 |
C57BL/6
|
508 |
3781.0 |
  |
| 5 |
C57BL
|
292 |
2712.3 |
  |
| 6 |
F1
|
335 |
2530.8 |
  |
| 7 |
CBA
|
286 |
2433.9 |
  |
| 8 |
tumors
|
466 |
2231.6 |
  |
| 9 |
AKR
|
193 |
1795.9 |
  |
| 10 |
DBA/2
|
178 |
1598.4 |
  |
| 11 |
B6
|
168 |
1481.9 |
  |
| 12 |
DBA
|
148 |
1410.2 |
  |
| 13 |
H-2k
|
138 |
1325.4 |
  |
| 14 |
carcinoma
|
315 |
1305.7 |
  |
| 15 |
B10
|
119 |
1238.4 |
  |
|
| 10 years (1999-12-23 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
mice
|
975 |
4052.0 |
  |
| 2 |
C57BL/6
|
170 |
1367.0 |
  |
| 3 |
BALB/c
|
133 |
1039.2 |
  |
| 4 |
mouse
|
158 |
754.8 |
  |
| 5 |
C57BL
|
46 |
508.2 |
  |
| 6 |
B6
|
51 |
475.8 |
  |
| 7 |
DBA/2
|
41 |
426.8 |
  |
| 8 |
tumors
|
61 |
379.6 |
  |
| 9 |
CBA
|
33 |
330.4 |
  |
| 10 |
B10
|
26 |
303.7 |
  |
| 11 |
Tg8
|
25 |
292.0 |
  |
| 12 |
carcinoma
|
62 |
290.0 |
  |
| 13 |
C57
|
23 |
279.8 |
  |
| 14 |
METHODS
|
69 |
270.6 |
  |
| 15 |
A/J
|
23 |
251.8 |
  |
|
| 365 days (2008-12-20 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
mice
|
23 |
85.8 |
  |
| 2 |
Fst
|
6 |
62.0 |
  |
| 3 |
C57BL/6
|
6 |
50.7 |
  |
| 4 |
testosterone
|
6 |
44.7 |
  |
| 5 |
TGF-beta/Smad
|
4 |
43.5 |
  |
| 6 |
T-cell factor-4
|
4 |
42.8 |
  |
| 7 |
BALB/c
|
5 |
37.9 |
  |
| 8 |
Dio2
|
3 |
35.9 |
  |
| 9 |
Dio3
|
3 |
35.9 |
  |
| 10 |
B6B-F1
|
3 |
33.7 |
  |
| 11 |
I. Photosensitizers
|
2 |
25.8 |
  |
| 12 |
Na
|
2 |
25.8 |
  |
| 13 |
P10
|
2 |
25.8 |
  |
| 14 |
PDT
|
2 |
25.8 |
  |
| 15 |
PWD/Ph
|
2 |
25.8 |
  |
|